Hui Liu

Dr. Hui Liu


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 July 2019 in Oncology Letters
Verified
Journal Article
Open access
PDF file
LLLiu Liu
Liu Liu
ZCZhilin Chen
Zhilin Chen
WSWonji Shi
Wonji Shi
HLHui Liu
Hui Liu
WPWeiyi Pang
Weiyi Pang
Breast cancer (BC) is one of the most prevalent forms of cancer globally. However, the practical relevance of the RNA expression‑based prediction of BC is not clearly understood and requires further study. Using gene expression data downloaded from The Cancer Genome Atlas (TCGA), a risk score staging classification was created using Cox's multiple regression and was used to predict the clinical outcomes of patients with BC. In total, 7 genes, including AC123595.1, leukocyte immunoglobulin‑like receptor B5, CD209 molecule, AL049749.1, lymphatic vessel endothelial hyaluronan receptor 1, transmembrane protein 190 and tubulin α 3D chain were identified in association with patient survival. The patients with lower risk scores had considerably improved survival rates than those with higher risk scores. Compared with other clinical factors, the risk score more accurately predicted the clinical outcome of patients with BC. In summary, 7 genes were identified using the Cox regression model, and subsequently used to develop a risk staging model for BC, which may be of use for the medical management of patients.

4 May 2024 in Ecotoxicology and Environmental Safety
Verified
Journal Article
Open access
SLShengle Li
Shengle Li
ZQZipeng Qiao
Zipeng Qiao
MHMeidie Huang
Meidie Huang
QLQiufeng Lao
Qiufeng Lao
QZQingquan Zhang
Qingquan Zhang
WPWeiyi Pang
Weiyi Pang
Microplastics (MPs) and benzo[a]pyrene (B[a]P) are prevalent environmental pollutants. Numerous studies have extensively reported their individual adverse effects on organisms. However, the combined effects and mechanisms of exposure in mammals remain unknown. Thus, this study aims to investigate the potential effects of oral administration of 0.5μm polystyrene (PS) MPs (1 mg/mL or 5 mg/mL), B[a]P (1 mg/mL or 5 mg/mL) and combined (1 mg/mL or 5 mg/mL) on 64 male SD rats by gavage method over 6-weeks. The results demonstrate that the liver histopathological examination showed that the liver lobules in the combined (5 mg/kg) group had blurred and loose boundaries, liver cord morphological disorders, and significant steatosis. The levels of AST, ALT, TC, and TG in the combined dose groups were significantly higher than those in the other groups, the combined (5 mg/kg) group had the lowest levels of antioxidant enzymes and the highest levels of oxidants. The expression of Nrf2 was lowest and the expression of P38, NF-κB, and TNF-α was highest in the combined (5 mg/kg) group. In conclusion, these findings indicate that the combination of PSMPs and B[a]P can cause the highest levels of oxidative stress and elicit markedly enhanced toxic effects, which cause severe liver damage.

30 July 2021 in Frontiers in Molecular Biosciences
Verified
Journal Article
Open access
WSWenjie Shi
Wenjie Shi
DHDaojun Hu
Daojun Hu
YXYu Xing
Yu Xing
RZRui Zhuo
Rui Zhuo
QLQiufeng Lao
Qiufeng Lao
WPWeiyi Pang
Weiyi Pang
Vacuolar protein sorting–associated protein 28 (VPS28), one of the four cytosolic proteins comprising the endosomal sorting complex required for the transport I (ESCRT-I) component, has been reported to be linked to various cancers. However, less evidence is available regarding the involvement of VPS28 in breast cancer. To this end, this study focused on exploring the function of VPS28 in breast cancer cells using the in silico analysis. VPS28 expression pattern data in breast cancer tissues were collected using the Cancer Genome Atlas (TCGA) and Clinical Proteomic Tumor Analysis Consortium (CPTAC) databases and analyzed to assess the association of VPS28 with breast cancer prognosis. The elevated VPS28 expression was found in breast cancer tissues and was associated with a poor prognosis (p < 0.001). A higher VPS28 expression indicated a short survival duration (HR = 2.43; 95% CI: 1.44–4.1; p < 0.001). The CCLE database showed that VPS28 was expressed in breast cancer cell lines. The upstream targets of VPS28 were identified using the mirDIP, starBase, and TargetScan online tools. The correlation and binding relationship between miR-491-5p and VPS28 was analyzed. VPS28 or miR-491-5p gain and loss of function experiments were performed to verify their potential effect on the biological functions of breast cancer cells. Knockdown of VPS28 was shown to suppress the biological functions and enhance the apoptosis of breast cancer cell lines. Micro RNA-491-5p, identified as a posttranscriptional regulator of VPS28, was downregulated in breast cancer tissues. In contrast to the miR-491-5p inhibitor, the miR-491-5p mimic could suppress the migration, wound healing ability, and proliferation, while accelerating apoptosis. However, co-transfection of VPS28 and miR-491-5p counteracted the effect of the miR-491-5p mimic on breast cancer cell functions. Thus, our in silico analysis demonstrates that miR-491-5p can suppress breast cancer progression by attenuating the expression of VPS28.

19 January 2024 in ACS Omega
Verified
Journal Article
Open access
QLQiuFeng Lao
QiuFeng Lao
LYLiJun Yang
LiJun Yang
SLShuZhen Liu
ShuZhen Liu
XMXiaoJun Ma
XiaoJun Ma
DTDeChan Tan
DeChan Tan
HLHui Liu
Hui Liu
Benzo-[a]-pyrene (B-[a]-P) and 2,2 ',4,4 '-tetrabromodiphenyl ether (BDE-47) are widespread environmental pollutants and can destroy thyroid function. We assessed the biochemical changes in the thyroid tissue of rats exposed to B-[a]P and BDE-47 using attenuated total reflection Fourier-transform infrared spectroscopy combined with support vector machine-(SVM). After B-[a]P and BDE-47 treatment in rats, the structure of thyroid follicles was destroyed and epithelial cells were necrotic, indicating that B-[a]P and BDE-47 may lead to changes of the thyroid morphology of the rats. These damages are mainly related to C= O stretch vibrations of lipids (1743 cm(-1)), as well as the secondary structure of proteins [amide I (1645 cm(-1)) and amide II (1550 cm(-1))], and carbohydrates [C-OH (1138 cm(-1)), C-O (1106 cm(-1), 1049 cm(-1), 991 cm(-1)), C-C (1106 cm(-1)) stretching] and collagen (phosphodiester stretching at 922 cm(-1)) vibration modes. When SVM was used for classification, there was a substantial separation between the control and the exposure groups (accuracy = 96%; sensitivity = 98%; specificity = 87%), and there was also a major separation between the exposed groups (accuracy = 93%; sensitivity = 94%; and specificity = 92%).

23 September 2025 in Biochemistry and Biophysics Reports
Verified
Journal Article
Open access
ZQZipeng Qiao
Zipeng Qiao
YTYongjun Tang
Yongjun Tang
SLShengle Li
Shengle Li
QLQiufeng Lao
Qiufeng Lao
YXYu Xing
Yu Xing
HLHui Liu
Hui Liu
Long non-coding RNAs (lncRNAs) play crucial roles in the progression of breast cancer (BC). The lncRNA small nuclear RNA host gene 16 (SNHG16), represents a lncRNA associated with tumor development. This study focuses on SNHG16 and its regulatory role in BC progression, validated through microarray analysis and in vitro experiments. The GEO datasets GSE65194 and GSE61304 were used to identify differentially expressed lncRNAs, GSE41922 and GSE45666 for differentially expressed miRNAs, and GSE29431 and GSE42568 for differentially expressed mRNAs. The TCGA database was used to validate the genes identified in the previous analyses. The regulatory pathways of SNHG16 were identified through differential gene analysis, target gene prediction, functional enrichment analysis, and protein-protein interaction network analysis. RT-qPCR, Western blot, CCK-8, cell migration, and cell knockdown experiments were performed for validation. Our study found that elevated expression levels of SNHG16 were associated with BC cell proliferation and poor prognosis. According to an in vitro knockdown assay, SNHG16 silencing inhibits the progression of BC. SNHG16 was found to positively regulate AURKA levels as a competitive sponge for hsa-let-7b-5p. The activity of the lncRNA SNHG16 can be triggered via the hsa-let-7b-5p/AURKA axes. These findings shed light on the novel molecular mechanisms underlying BC progression.

18 November 2025 in Eurasian Journal of Medicine and Oncology
Verified
Journal Article
Open access
PDF file
HLHui Liu
Hui Liu
SBSomchai Bovornkitti
Somchai Bovornkitti
SSSarisak Soontornchai
Sarisak Soontornchai
XQXiaoqiang Qiu
Xiaoqiang Qiu
Wenjie ShiWenjie Shi
Wenjie Shi
Introduction: Inflammatory responses play an essential role in metabolic dysfunction-associated steatotic liver disease (MASLD). Objective: This study investigates the mediating role of systemic inflammation in the pathophysiology of heavy metal-induced MASLD. Methods: We employed data from the National Health and Nutrition Examination Survey from 2017 to 2020 to examine the relationship between 16 heavy metals and MASLD. Vibration-controlled transient elastography was used to evaluate hepatic steatosis and determine the Systemic Immune Inflammation Index (SII) and Systemic Inflammatory Response Index (SIRI). Data analysis was conducted using linear or logistic regressions, weighted quantile sum regression (WQS), restricted cubic spline, and mediation effect models. Results: The study involved 2,934 patients, with an average age of 44.86 ± 20.58 years, of whom 50.23% were female. Urinary cadmium (Cd), lead (Pb), arsenic, mercury, and tungsten were all positively associated with MASLD risk. The WQS model showed a strong positive correlation between a high amount of urea-metal mixtures and higher SII, SIRI, and MASLD (p<0.01). Mediation analysis found that systemic inflammation mediated the effects of single metals (Cd, cesium [Cs], and Pb) on MASLD risk. The mediation proportions of urinary metal mixtures on MASLD risk, mediated by SII and SIRI, were 57.84% and 65.21%, respectively. Conclusion: Based on the findings, systemic inflammation partially mediates the association between metals such as Cd, Cs, and Pb—and their combined effects—and metabolic dysfunction and steatosis. Hence, reducing systemic inflammation could help prevent and treat metal-related steatohepatitis caused by environmental exposure.